Assessment of efficacy and safety of imatinib as an adjunct host-targeted therapy for parasite clearance in chloroquine-resistant malaria: a prospective case control study
Crossref DOI link: https://doi.org/10.1186/s43162-025-00399-9
Published Online: 2025-01-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zubair Ahmed, Fazeel
P, Shaifulla
Text and Data Mining valid from 2025-01-09
Version of Record valid from 2025-01-09
Article History
Received: 8 December 2024
Accepted: 5 January 2025
First Online: 9 January 2025
Declarations
:
: The authors declare no competing interests.